In summary, MEK inhibitors effectively decrease volume of plexiform neurofibromas and may be also be beneficial in cases with a high cutaneous neurofibroma burden or complicated spinal neurofibromas. This evidence concerns the gene MAP2K7 and plexiform neurofibroma.